Isolation and Characterization of Lytic Bacteriophage Against Multi-drug Resistant Pseudomonas aeruginosa

Archana Maharjan1, Roshan Nepal1, Gunaraj Dhungana1

  • 1Central Department of Biotechnology, Institute of Science and Technology, Tribhuvan University, Kirtipur, Nepal.

Abstract

Insights

Lytic phages offer a promising alternative to antibiotics for combating multi-drug resistant Pseudomonas aeruginosa. Researchers isolated phage øCDBT-PA31, effective against resistant strains and stable under harsh conditions.

Area of Science:

  • Microbiology
  • Virology
  • Biotechnology

Background:

  • Pseudomonas aeruginosa is a significant cause of healthcare-associated infections.
  • Rising antimicrobial resistance necessitates novel therapeutic strategies.
  • Phage therapy, using viruses to target bacteria, is a potential personalized treatment.

Purpose of the Study:

  • To isolate and characterize lytic phages effective against multi-drug resistant Pseudomonas aeruginosa.
  • To evaluate the stability and host range of isolated phages.
  • To explore phage therapy as an alternative to antibiotics.

Main Methods:

  • Isolation of lytic phages using the soft agar overlay technique.
  • Determination of phage characteristics (thermal/pH stability, latent period, burst size) via one-step growth assay.
  • Host range determination by spot assay and protein profiling for characterization.

Main Results:

  • Three Pseudomonas phages (øCDBT-PA31, øCDBT-PA56, øCDBT-PA58) were isolated.
  • Phage øCDBT-PA31 exhibited a broad host range, lysing multi-drug resistant P. aeruginosa.
  • øCDBT-PA31 demonstrated stability across a wide temperature (50°C) and pH (3-11) range, with a latent period of 30 minutes and burst size of 423-525 PFU/cell.

Conclusions:

  • Lytic phages represent a viable alternative treatment for multi-drug resistant bacterial infections.
  • Phage therapy provides a potential solution when conventional antibiotics are ineffective.
  • Further research into specific phages like øCDBT-PA31 is warranted for clinical application.